Post-stent placement, antiplatelet therapy is indeed crucial to prevent blood clots from forming on the stent, thereby reducing

Post-stent placement, antiplatelet therapy is indeed crucial to prevent blood clots from forming on the stent, thereby reducing the risk of heart attacks or strokes. Medications like aspirin and P2Y12 inhibitors (such as clopidogrel, ticagrelor, or prasugrel) are commonly used for this purpose (MedlinePlus, n.d.). However, it’s important to note that the choice of medication and its dosage should be individualized based on the patient’s specific condition and risk factors. Regular follow-ups with the healthcare provider are also essential to monitor the patient’s response to the treatment and adjust the therapy as needed.” Your statement is correct. Furosemide is a loop diuretic that is often used in the management of congestive heart failure (CHF). It works by inhibiting the reabsorption of sodium and chloride in the kidneys, which leads to an increase in urine output. This helps to reduce fluid overload in the body, a common problem in CHF. However, as you mentioned, furosemide can cause electrolyte imbalances, particularly low potassium (hypokalemia) and low sodium (hyponatremia). This is because the increased urine output can lead to a loss of these important electrolytes. condence please